Clinical trials for Cancer in United States

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

Study ID: NCT06268665

Sponsor

Eve tobogganist

Efficacy and Safety of REC-2282 in Patients With Progressive Neurofibromatosis Type 2 (NF2) Mutated Meningiomas

Study ID: NCT05130866

Sponsor

Recursion Pharmaceuticals Inc.

Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions

Study ID: NCT03465774

Sponsor

M.D. Anderson Cancer Center

A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)

Study ID: NCT05576974

Sponsor

University of Texas Southwestern Medical Center

Study of Olutasidenib and Temozolomide in HGG

Study ID: NCT06161974

Sponsor

Rigel Pharmaceuticals

Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca

Study ID: NCT04988074

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Study ID: NCT03452774

Sponsor

Massive Bio, Inc.

Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma.

Study ID: NCT06727565

Sponsor

Gilead Sciences

Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer

Study ID: NCT05800574

Sponsor

Fox Chase Cancer Center

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

Study ID: NCT04329065

Sponsor

University of Washington